Aramark (ARMK) Q1 2026 Earnings Call Transcript
Aramark (ARMK) Q1 2026 Earnings Call Transcript
Fiscal Year: November - October
Aramark (ARMK), listed on the NYSE, has a market capitalization of $. As of Feb 21, 2026, the stock is trading at $40.92 per share, offering investors a clear view of its current market value. Aramark is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 34.41, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. Aramark also offers a dividend yield of 1.18%, making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that Aramark (ARMK) may be overvalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for Aramark is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for Aramark, Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for Aramark is 45.87, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, Aramark (ARMK) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether Aramark (ARMK) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be overvalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of Aramark (ARMK) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of Aramark. To access the full SS Score, consider upgrading your subscription.
Aramark is a significant player in the industry sector, with a market capitalization of $ and a competitive P/E ratio of 34.41. Investors should compare these metrics with industry peers to gauge whether Aramark is outperforming or underperforming within its sector.
Aramark (ARMK) Q1 2026 Earnings Call Transcript
PHILADELPHIA--(BUSINESS WIRE)--Aramark (NYSE: ARMK) today reported first quarter fiscal 2026 results. "We're very pleased with the strong results delivered in the quarter, which included extraordinary...
PHILADELPHIA--(BUSINESS WIRE)--Aramark's (NYSE: ARMK) Board of Directors approved a quarterly dividend of $0.12 cents per share of common stock payable on March 4, 2026 to stockholders of record at th...
PHILADELPHIA--(BUSINESS WIRE)---- $ARMK--Aramark (NYSE: ARMK) has been recognized on Fortune's 2026 list of World's Most Admired Companies, earning the No. 4 spot in the Diversified Outsourcing Servic...
PHILADELPHIA--(BUSINESS WIRE)--Aramark Collegiate Hospitality today announced the launch of The Gathering Place TM, an innovative residential dining concept designed with direct input from students to...
Aramark acquired a 90% stake in Entier early last year, a deal which combined two of three major offshore catering suppliers in the U.K.
Britain's competition watchdog ordered U.S.-based food service and facilities provider Aramark to sell offshore catering firm Entier on Thursday, after an investigation found the merger would substant...
PHILADELPHIA--(BUSINESS WIRE)--Aramark (NYSE:ARMK), a global leader in food and facilities management, announced that it will host a conference call to review its first quarter fiscal 2026 results on ...
PHILADELPHIA--(BUSINESS WIRE)--Aramark (NYSE: ARMK) today announced a landmark 15-year partnership with the University at Albany (UAlbany), a public research university in Albany, NY, to deliver a bol...
PHILADELPHIA--(BUSINESS WIRE)--Aramark Destinations is celebrating a year of impactful community partnerships across its national park and conservation properties, reinforcing its commitment to suppor...
PHILADELPHIA--(BUSINESS WIRE)--Aramark (NYSE:ARMK), a global leader in food and facilities management, announced the successful completion of a favorable repricing for the Company's 2030 Term Loan B, ...
Aramark remains a Hold as the near-term FY26 outlook is unattractive despite strong commercial momentum and major contract wins. Q4 2025 revenue growth was inflated by a 53rd week, and underlying orga...
PHILADELPHIA--(BUSINESS WIRE)--Aramark Correctional Services, LLC, a division of Aramark (NYSE: ARMK), has been awarded a statewide partnership with the Alabama Department of Corrections (ADOC) to del...
Alphabet shares rose 38% during the quarter. This represents a striking $810 billion increase in market value. Samsung shares rose 36% in the quarter, adding over $100 billion of market value. Samsung...
PHILADELPHIA--(BUSINESS WIRE)--Aramark SeniorLife+ today announced the launch of a new Consultative Services program, designed to meet the needs of senior living communities, strengthen operations, an...
Shares of Aramark (NYSE:ARMK) fell around 6% on Monday after the company reported downbeat earnings for the fourth quarter.
Aramark ( ARMK) Q4 2025 Earnings Call November 17, 2025 8:30 AM EST Company Participants Felise Kissell - Investor Relations & Corporate Affairs Executive John Zillmer - CEO & Director James Tarangel...
Aramark (ARMK) is upgraded to a 'BUY' rating with a maintained share price target, reflecting strong recent results and ongoing operational improvements. ARMK delivered double-digit operating income a...
PHILADELPHIA--(BUSINESS WIRE)--Aramark (NYSE: ARMK) today reported results for the fourth quarter and full year of fiscal 2025. “Fiscal 2025 represented many consequential milestones for the Company, ...
Aramark (NYSE: ARMK) will release earnings results for the fourth quarter, before the opening bell on Monday, Nov. 17.
PHILADELPHIA--(BUSINESS WIRE)--Aramark's IN2WORK (I2W) program, designed to help formerly incarcerated citizens find meaningful work after release, is launching a new culinary track designed to teach ...
PHILADELPHIA--(BUSINESS WIRE)--Aramark (NYSE:ARMK), a global leader in food and facilities management, announced that it will host a conference call to review its fourth quarter and full year fiscal 2...
PHILADELPHIA--(BUSINESS WIRE)--Aramark (NYSE: ARMK) is advancing its position as the leader in artificial intelligence innovation in hospitality with the rollout of Culinary Co-Pilot (CCP)—a proprieta...
PHILADELPHIA--(BUSINESS WIRE)--Aramark Healthcare+, a national leader in healthcare dining, nutrition, and facilities services, has once again secured the top spot in the Large Supplier category on Mo...
PHILADELPHIA--(BUSINESS WIRE)---- $ARMK--Aramark (NYSE: ARMK) and the University of Pennsylvania Health System (UPHS) today announced a new multi-year agreement beginning in early 2026 to provide pati...
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
| Year | FCF Estimate | % | # Analysts |
|---|---|---|---|
| 2026 | 511.47M | Analyst x5 | |
| 2027 | 620.66M | 21.35% | Analyst x5 |
| 2028 | 683.67M | 10.15% | Analyst x3 |
| 2029 | 587.00M | -14.14% | Analyst x1 |
| 2030 | 622.00M | 5.96% | Analyst x1 |
| 2031 | 621.95M | -0.01% | Est @0.0% |
| 2032 | 626.71M | 0.76% | Est @0.8% |
| 2033 | 634.89M | 1.31% | Est @1.3% |
| 2034 | 644.84M | 1.57% | Est @1.6% |
| 2035 | 656.54M | 1.81% | Est @1.8% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
| Year | FCF | Discount Factor | PV of Future FCF |
|---|---|---|---|
| 2024A | 299.09M | 1.00 | 299.09M |
| 2025A | 431.80M | 1.00 | 431.80M |
| 2026E | 511.47M | 1.09 | 470.66M |
| 2027E | 620.66M | 1.18 | 525.56M |
| 2028E | 683.67M | 1.28 | 532.72M |
| 2029E | 587.00M | 1.39 | 420.90M |
| 2030E | 622.00M | 1.52 | 410.40M |
| 2031E | 621.95M | 1.65 | 377.63M |
| 2032E | 626.71M | 1.79 | 350.15M |
| 2033E | 634.89M | 1.95 | 326.41M |
| 2034E | 644.84M | 2.11 | 305.08M |
| 2035E | 656.54M | 2.30 | 285.82M |
| Terminal | 10.90B | 2.30 | 4.75B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.